23.07.2021
Press Release

SOPHiA GENETICS Announces Pricing of Initial Public Offering

BOSTON and LAUSANNE, Switzerland, July 22, 2021 — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated fees and offering expenses payable by SOPHiA GENETICS SA, are expected to be approximately $234 million. In addition, SOPHiA GENETICS SA has granted the underwriters a 30-day option to purchase up to 1,950,000 additional ordinary shares. The ordinary shares are expected to begin trading on the Nasdaq Global Select Market on July 23, 2021 under the symbol “SOPH.” The offering is expected to close on July 27, 2021, subject to customary closing conditions.

J.P. Morgan, Morgan Stanley, Cowen and Credit Suisse are acting as joint book-running managers for the offering.

Read more